The small molecule company with end-to-end capabilities
Please log in for more information
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.
Cambrex is an innovative life sciences company that provides pharmaceutical products, expertise and technologies that accelerate small molecule therapeutics into markets across the world.
With over 35 years of active pharmaceutical ingredient development and manufacturing expertise, a team of more than 1,200 experts, and a strong presence in the USA and Europe, Cambrex is tried and trusted across branded and generic API markets.
Cambrex offers an end-to-end partnership for the research, development and manufacture of small molecule APIs at every stage of the lifecycle. Its capabilities include classical and advanced chemistry, enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances.